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ABSTRACT: The use of a bifunctional cinchona/thiourea organocatalyst for the direct and α-stereoselective glycosylation of 2-
nitrogalactals is demonstrated for the first time. The conditions are mild, practical and applicable to a wide range of glycoside accep-
tors with products being isolated in good to excellent yields. The method is exemplified in the synthesis of mucin type Core 6 and 7 
glycopeptides.  
The stereoselective synthesis of glycosides is still one of the 
remaining challenges in oligosaccharide synthesis. 2-Amino 
glycosides, typically present in the N-acylated form, are an 
important class of glycans that are often found as integral 
components of biologically relevant oligosaccharides and 
glycoconjugates. In particular, 2-acetamido-2-deoxy-D-O-
galactopyranosides α-linked to the OH group of serine, 
threonine or other glycosides are a common motif in a number 
of proteins such as mucins, cell membrane glycoproteins, 
blood group determinants, immunoglobulins, antifreeze 
glycoproteins, and glycoprotein hormones.1-4 In addition, 2-
amino-2-deoxy-O-glycosides are also constituents of several 
nucleosides and aminoglycoside antibiotics, e.g. streptomycin, 
kanamycin B, neomycins, paromomycins, kasugamycin, 
pyranmycins, and lividomycins.5 Thus, these compounds 
represent an important synthetic target. However, despite 
many efforts in the area, the synthesis of 1,2-cis 
aminoglycosides still remains particularly difficult since most 
common N-protecting groups (e.g. amides, carbamates) 
exhibit 1,2-trans-directing behavior during the glycosylation 
reaction favoring the formation of β-linked products.6 2-
Nitroglycals have been shown to be useful glycosyl donors for 
the synthesis of aminoglycosides whereby the nitro group 
serves as a non-participating latent amino functionality.7-11 
Base-catalyzed conjugation of alcohols to 2-nitroglycals has 
been reported by the Schmidt group for forming α- and β-
linked 2-amino-2-deoxy-O-glycosides.12 Moreover, the α/β-
selectivity of this concatenation reaction is highly dependent 
on the nature of the base and nucleophile employed in the 
reaction.6, 13-16 
 Stemming from our interest in the development of novel 
catalytic systems for the stereoselective synthesis of glyco-
sides,17-20 we decided to focus our efforts on the organocatalyt-
ic preparation of 2-deoxy-2-amino-O-galactosides. Herein, we 
report the development of a mild, efficient and stereoselective 
bifunctional organocatalyst for the direct glycosylation of 2-
nitrogalactals and its application in the synthesis of mucin type 
α-O-linked 2-acetamido-2-deoxy-glycoconjugates. 
 
 
Figure 1. Proposed general activation of nitroalkenes by bi-
functional thiourea catalysts. 
Organocatalysis has been successfully applied to the 
synthesis of oligosaccharides.15,18-25 Our team reported the use 
of Schreiner’s thiourea to promote the highly α-selective 
glycosylation of galactals with a number of OH nucleophiles.20  
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In addition, the organocatalytic enantioselective addition of 
soft carbon nucleophiles and thiols to nitroalkenes has been 
documented by various research groups.26-33 A common 
feature in all the catalytic systems employed in these 
conjugate addition reactions is the use of bifunctional catalysts 
that contains both a thiourea and a basic amine group. It is 
proposed that while the thiourea functionality coordinates to 
the nitro group, and thus increases the electrophilicity of the 
nitroalkene, the pendant amine activates and directs the 
addition of the nucleophile into the prochiral alkene.26,31,34 We 
hypothesised that such bifunctional organocatalysts would be 
ideally suited as mild promoters for the stereoselective 
glycosylation of 2-nitroglycals. 
 
Table 1. Initial catalyst and solvent screen in the glycosylation 
of 2-nitrogalactal 1. 
 
Entry Catalyst Solvent Yield (%)[a] α:β[a] 
1 3a CH2Cl2 81 0.8:1 
2 3b CH2Cl2 79 1:0.8 
3 3c CH2Cl2 80 1:1 
4 3d CH2Cl2 5 0.9:1 
5 3e CH2Cl2 16 1:1 
6 3f CH2Cl2 0 N/A 
7 3b THF 66 2.4:1 
8 3b PhCH3 78 2.4:1 
9 3b PhCF3 85 2.4:1 
10 3b 1,4-Dioxane 75 2.4:1 
11 3b MeCN 87 4:1 
12 3b DMF[b] 29 1.5:1 
13 3b DMSO[c] 0 N/A 
[a] from 1H NMR. N/A = not applicable. [b] Reaction carried out at 82 
oC. [c] Reaction carried out at 90 oC. 3a, 3c and 3d were also screened in 
MeCN affording 4:1 α:β ratios, while 3e and 3f in MeCN yielded little 
(<15 %) or no product, respectively. 
 
Our experiments began with a screening of a series of 
commercial bifunctional cinchona alkaloid/thiourea catalysts 
for their ability to promote the stereoselective glycosylation of 
perbenzylated 2-nitrogalactal 112 with glucoside acceptor 2.34 
As summarized in Table 1, the glycosylation reaction with 10 
mol % of urea 3a35 or thiourea 3b36 in CH2Cl2 proceeded with 
good conversions to product 412 (79-81%) after 48 h, albeit 
giving a ~1:1 α:β anomeric mixture (Table 1, entries 1 and 2). 
Changing the catalyst to the opposite pseudo-enantiomer, as in 
thiourea 3c,36 did not cause any significant changes to yield or 
stereochemical outcome of the reaction (Table 1, entry 3). It 
was also observed that the presence of both the (thio)urea and 
amine functionality were required for activity, as no reaction 
was observed when using thiourea 3f38 and very poor 
conversions were achieved with carbamate 3d39 or cinchona 
alkaloid 3e40 as the sole promoters after 48 h (Table 1, entries 
4-6).  
Next, we decided to explore solvent effects using 3b as the 
model catalyst (See Table 2). Pleasingly, an increase in 
selectivity towards the desired α-anomer was achieved when 
using either THF, toluene, trifluorotoluene or 1,4-dioxane as 
the reaction solvent, with MeCN being the optimum choice 
affording the product in 87% yield and with an improved 4:1 
α:β ratio (Table 2, entry 5). While reactions carried out in 
DMF or DMSO were detrimental to yield and stereocontrol 
(entries  12 and 13). These results are consistent with MeCN 
helping to stabilize a transient ion pair intermediate which 
leads to an enhancement of the stereo-chemical influence of 
the catalyst.41  
To investigate if the spatial presentation of the key 
functionalities (thio)urea and amine could have an effect on 
the outcome of the reaction, additional catalysts, C-5’ 
substituted cinchona alkaloid/urea 3g,29 thiourea 3h42 and bis-
cinchona alkaloid thioureas 3i43 were prepared and subjected 
to the glycosylation reaction in MeCN at reflux as before. It 
was found that only thiourea 3i (Table 2, entry 3) showed an 
increase in reactivity (94% conversion after 48 h) and a similar 
anomeric selectivity towards the α-product as observed with 
3b (Table 1, entry 11). It is important to note that reactions 
carried out using a 10 mol % 1/1 mixture of 3e and 3f in 
MeCN proceeded in moderate yields of 55% after 48 h and 
gave an almost equimolar mixture of anomers (entry 4). These 
results further demonstrate that the 3D architecture of the 
catalyst is important for both reactivity and stereocontrol.  
 
Table 2. Catalyst optimization in the glycosylation of 2-
nitrogalactal 1. 
 
Entry Catalyst  (mol %) 
Time  
(h) 
Yield  
(%)[a] α:β
[a] 
1 3g (10) 48 57 1:0.9 
2 3h (10) 48 75 3:2 
3 3i (10) 48 94  4:1 
4 3e+3f (10) 48 50 1:0.8 
5 3i (10) 24 72 4:1 
6 3i (20) 24 82 4:1 
7 3i (30) 24 87 4:1 
8 3i (30) 16 82 4:1 
9 3i (50) 24 81 4:1 
 [a] from 1H NMR 
While it is well known that cinchona-based thioureas can 
self-associate either at high catalyst loading and low 
temperatures and become less active catalysts,44-47  bis-
cinchona alkaloid organocatalysts such as 3i are designed to 
prevent any self-association,43,48,49 which should allow us to 
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increase catalyst loadings in hope of improving reaction rate 
without erosion of diastereoselectivity. Further optimization of 
the reaction with 3i (Table 2, entries 5-9) established that 30 
mol % catalyst loading shortened reaction times and glycoside 
products were obtained in 82-87% after 16-24 h (entries 7 and 
8), with higher catalyst loadings not offering any further 
improvements (entry 9).  
 
Table 3. Glycosylation of 2-nitrogalactals 1 and 5 with a varie-
ty of glycosyl acceptors.  
 
[a] Both anomers were separated by Flash Column 
Chromatography, see the Supporting Information for details. 
 
Having established optimal reaction conditions, our attention 
was then turned to exploring the scope of the organocatalytic 
glycosylation using a range of versatile building blocks (Table 
3). In general, glycosylations involving glycosyl donors 1 and 
5, which were prepared from commercial D-galactal (see ESI 
for details), and both reactive and sterically hindered acceptors 
in the presence of 3i proceeded in moderate to excellent yields 
within 16-48 h, demonstrating that the catalyst tolerates the 
presence of acetals, alkenes, ethers, esters and carbamates. 
Glycosylations with primary alcohols afforded high yields 
with a preference for the α-products. Thus, glycosides 6a, 6b, 
7a, 7b and 7c were isolated in 96-85% yields and 2:1 to 4:1 
α:β ratios. Interestingly, reactions with glycosyl acceptors 
bearing electron-withdrawing protecting groups afforded 
disaccharides (6c and 6d) with complete α-stereocontrol, 
albeit in moderate yields (45%).50 It is well-established that 
disarming substituents reduce the electron density of the 
neighboring hydroxyl group, lowering its nucleophilicity and 
this has been shown to improve stereoselectivity as the 
reaction can be carried out in a more controlled manner.51 
Pleasingly, glycosylations of benzyl-protected 1 with Boc-
functionalized serine or threonine went smoothly to give the 
corresponding glyco-conjugates 6e52 and 6f14,52 in 83% and 
60% yield, respectively, and with a 3:1 α:β anomeric 
selectivity. It is noteworthy that reaction of C-6 silyl protected 
galactal 2 and protected serine afforded 7d with an improved 
α:β ratio of 9:1 and 74% yield.  
To showcase the methodology, the synthesis of mucin type 
Core 6 and 7 glycoconjugates53-55 10 and 13 was attempted 
using the developed organocatalytic conditions (Scheme 2). 
Starting from α-linked 2-nitrogalactoside 7d, selective silyl ether 
removal with TBAF afforded monohydroxylated 8 in 82% yield, 
ready to be glycosylated. Glycosylation of 8 with O-benzyl-
protected 2-nitrogalactal 1 using 30 mol % of 3i in MeCN 
afforded Core 6 disaccharide 9 in 60% yield as a separable 3:2 
α:β mixture. The presence of a C-2 nitro group in both donor and 
acceptor that can interact with the catalyst may account for the 
loss of stereoselectivity in this reaction. Reduction of the nitro 
groups from α-glycoside 9 using Zn/HCl in a mixture of 
AcOH/THF/H2O, followed by N-acetylation with acetic anhydride 
in pyridine furnished target 10 in 78% yield over the 2 steps. 
Alternatively, glycosylation of 8 using N-Troc-protected 
glucosamine donor 11 yielded Core 7 disaccharide 12 in 86% 
yield and with complete β-stereocontrol. Concomitant Zn 
reduction of the nitro and NHTroc protecting groups in 12 and 
subsequent N-acetylation performed using the same reaction 
conditions as before, afforded 13 in 40% yield over the 2 steps. 
 
Scheme 1. Synthesis of Mucin-type Core 6 and 7 glycosides 10 
and 13. 
 
In conclusion, we have described the first application of a 
bifunctional cinchona/thiourea organocatalyst for the direct 
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and stereoselective glycosylation of 2-nitrogalactals to afford 
α-O-linked-2-amino-2-deoxygalactosides in moderate to 
excellent yields. The method is mild, practical and widely 
applicable to a range of nucleophile acceptors. Furthermore, 
we have demonstrated the applicability of the catalyst in the 
synthesis of Core 6 and 7 mucin type α-O-linked 
glycoconjugates. Overall, the results reported herein 
demonstrate that in addition to solvent effects and the 
influence of the nucleophile acceptor, a chiral organocatalyst 
can be used to affect the stereo-outcome of these glycosylation 
reactions. Efforts are currently underway to develop new and 
improved organocatalytic systems that can give us complete 
stereo-control. 
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